Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 150 for

Edit search filters
  1. A Study to Evaluate TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD)

    Jacksonville, FL

  2. Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients with IBS-D

    Rochester, MN

  3. Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects with Moderate to Severe Crohn's Disease

    Rochester, MN

  4. A Study to Evaluate the Effectiveness, Safety and Movement of Ustekinumab in Pediatric Patients with Ulcerative Colitis

    Rochester, MN

  5. Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis

    Rochester, MN

  6. A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433

    Rochester, MN

  7. Medication Therapy Management to Optimize Care Through Effective Resource Management in Inflammatory Bowel Disease

    La Crosse, WI, Eau Claire, WI, Mankato, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study to Evaluate the Effectiveness and Safety of MEDI2070 in Subjects with Active Moderate to Severe Crohn's Disease

    Rochester, MN

  9. An Extension Study of Oral Ozanimod for Moderately-to-Severely Active Crohn's Disease

    La Crosse, WI

  10. A Study to Evaluate the Long-Term Effectiveness, Safety, and Tolerability of Repeated Administration of ABT-494 in Patients with Crohn's Disease

    Rochester, MN

.

Mayo Clinic Footer